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Abstract 
Suzuki cross-coupling polymerisation of aryldibromides and aryldiboronate esters in a 
sodium dodecyl sulfate (SDS)-stabilised miniemulsion provides a versatile and direct route to 
fluorescent conjugated polymer nanoparticles (CPNs). These nanoparticles have a conjugated 
backbone based on poly(9,9-dioctylfluorene) (PFO), however, significant structural diversity 
is introduced by incorporation of electron withdrawing, heterocyclic comonomers (5-50 mol. 
%) in order to tune the emission wavelengths from blue to far-red/near-infrared. The robust 
nature of the polymerisation methodology allows for rapid assessment of the relationship 
between polymer composition, chain morphology and optical properties of the resultant 
CPNs. Moreover, the CPNs (after a simple and rapid purification step) can be used directly in 
fluorescence-based intracellular labelling experiments (in HCT116 cells), in which they 
display low cytotoxicity at biologically-useful concentrations.   
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1. Introduction 
Conjugated polymer nanoparticles (CPNs), sometimes referred to as conjugated polymer 
dots, have been examined for a wide range of fluorescence-based cellular labelling and 
biomedical imaging applications. In vitro, CPNs display low cytotoxicity and can be 
internalized by cells through several active mechanisms that depend on the size and nature of 
the nanoparticle surface.[1-4] Recent developments include the use of CPNs for in vivo 
targeted bioimaging of tumours, highlighting the potential of these materials as molecular 
imaging probes in a clinical setting.[5-9] CPNs do not show the undesirable fluorescence 
blinking behaviour and inherent toxicity associated with heavy-metal (e.g. Cd, Pb) derived 
quantum dots that are often used in similar applications.[10, 11] Two methods for the 
formation of CPNs have dominated literature reports to-date: i) nanoprecipitation, in which a 
dilute solution of a conjugated polymer (CP) in a water miscible, ‘good solvent’ (usually 
tetrahydrofuran) is added rapidly to a non-solvent (water),[12-14] and ii) miniemulsion, in 
which a solution of a CP in a non-water miscible, volatile solvent (e. g. dichloromethane) is 
emulsified in an aqueous solution of an appropriate surfactant, followed by solvent 
evaporation.[15-17] Both of these processing techniques are relatively straightforward and 
applicable to a range of commercially available CPs. The major limitation of these 
approaches is a lack of scalability: nanoprecipitation is particularly problematic in this respect 
in that it can only be achieved using very dilute polymer solutions and thus the resultant CPN 
dispersions have low solids contents (typically < 500 ppm). Miniemulsion of pre-formed CPs 
can be used to produce stable CPN dispersions at higher concentrations, but this approach 
necessitates the use of a multistep procedure in which the CP is initially prepared and isolated 
using conventional synthetic methods prior to subsequent dispersion in the miniemulsion. 
In an effort to minimize these limitations, various research groups have developed synthetic 
routes to CPNs in which the polymerisation and nanoparticle formation are achieved 
concurrently.[7, 18-24] The various classes of light-emitting CPs from which formation of 
CPNs is desirable are structurally diverse and, moreover, their optical bandgap (and 
consequently their fluorescence emission wavelength) is directly controlled by the chemical 
composition of the polyaromatic backbone. Consequently, the scope of any direct synthetic 
route to CPNs is very much reliant on the versatility of the underlying polymerisation 
technique. Weder et al. pioneered this one-pot approach to CPNs, through their early report 
of the synthesis of hyperbranched poly(phenylene ethynylene) (PPE)  nanoparticles via 
Sonogashira coupling of A2 + B2 + A3 monomers (where A = bromo/iodo, B = ethynyl) in 
emulsified droplets of toluene in an aqueous solution of the ionic surfactant sodium 
dodecylsulfate (SDS).[18] Most notably, the authors demonstrated that use of an ultrasonic 
bath for emulsification enabled the synthesis of fluorescent nanoparticles with average 
diameters ranging from 400-500 nm. The scope for heterogeneous Sonogashira 
polymerisation reactions to be used in the direct synthesis of PPE-based CPNs has since been 
considerably extended by Mecking et al.[19] Here the authors focused on A2 + B2 step-
growth reactions, employing the same catalytic system (Pd(PPh3)4, CuI, diisopropylamine), 
dispersed solvent (toluene) and surfactant (SDS) as the earlier report. More rigorous 
sonication prior to polymerisation was found to enable the formation of smaller nanoparticles 
(average diameter = 60-120 nm), which were of an appropriate size for use in intracellular 
imaging of HeLa cells. Moreover, it was demonstrated that incorporation of varying amounts 
of fluorenone or pyrolopyrrole comonomers into the polymer backbone provided access to 
blue, green or far-red/near infrared (FR/NIR) emitting CPNs.  
Suzuki coupling is widely used for the synthesis of both linear and branched CPs. Unlike 
Sonogashira coupling, Suzuki reactions involve aryl-aryl coupling (of aryl bromides with aryl 
boronic acids/boronate esters) and the resultant CPs thus have fully aromatic π-conjugated 
backbones. Due to the ubiquity of Suzuki coupling in CP synthesis, many appropriate, 
mutually-reactive A2 and B2 monomers (where A = bromo, B = boronic acid/boronate esters) 
are commercially available. There have been various attempts to develop heterogeneous 
Suzuki polymerisation reactions for the direct synthesis of CPNs. [21-24]  Liu et al. have 
explored the use of a non-ionic surfactant (Tween 80) for the heterogeneous, Suzuki 
polymerisation reaction of either 2,7-dibromo-9,9-dioctylfluorene or 4,7-dibromo-2,1,3-
benzothiadiazole with a slight excess of 9,9-dioctylfluorene-2,7-diboronic acid bis(1,3-
propanediol) ester and a small amount of 1,3,5-tribromobenzene (2 mol. %).[21] These 
reactions provide blue or green fluorescent CPNs (average diameter = 100 – 200 nm) 
comprised of CPs with a hyperbranched structure. We have recently demonstrated that when 
carried out at room temperature, Suzuki emulsion polymerisation reactions with Triton-X102 
as surfactant produce either rod-like or spherical nanoparticles, depending on the chemical 
structure of the conjugated polymer.[24]  
The use of ionic surfactants in heterogeneous Suzuki polymerisation has advantages for 
emulsion stability where higher temperatures are required and also makes surfactant removal 
during purification steps less challenging. Ionic surfactants typically have higher critical 
micelle concentrations (CMCs) and lower micellar molecular weights (MMWs) than non-
ionic surfactants, rendering them readily amenable to removal by dialysis. Furthermore, ionic 
surfactants often have much higher cloud points than their non-ionic counterparts (usually > 
100 °C). Mecking and co-workers have reported the direct synthesis of poly(9,9-
dioctylfluorene) CPNs via the Suzuki polymerisation reaction of an A-B type monomer, 2-
(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-7-bromo-9,9-dioctylfluorene, in an SDS-
stabilised miniemulsion using Pd(PPh3)4 as a catalyst and sodium hydroxide as base.[23] 
<Scheme 1 inserted her> 
Destabilisation of the miniemulsion was avoided by using the minimum amount of base (2 
mol. equivalents) necessary to promote the catalytic reaction. A similar approach has since 
been employed for the synthesis of CPNs by reaction of 9,9-dioctylfluorene-2,7-diboronic 
acid bis(1,3-propane-diol) ester and 1,3,5-dibromobenzene in a miniemulsion that was 
stabilised by the cationic surfactant cetyl trimethylammonium bromide.[22] Both of these 
reports provide useful strategies for the direct synthesis of CPNs with relatively small 
diameters (ca. 40-150 nm), but are limited in their scope in that both reports focused on the 
preparation of fluorene homopolymers. 
In order to demonstrate that Suzuki miniemulsion polymerisation reactions are robust, 
generally applicable and afford considerable structural diversity, we herein report the use of 
this technique for the polymerisation of a range of A2 + B2 type monomers. All reactions 
contain 50 mol. % of 2,2’-(9,9-dioctyl-9H-fluorene-2,7-diyl)bis(4,4,5,5-tetramethyl-1,3,2-
dioxaborolane), 2, as the B2 monomer: structural variety is achieved through reaction with 
different A2 comonomers to copolymers of poly(9,9-di-n-octylfluorenyl-2,7-diyl) (PFO). This 
approach provides access to either alternating co-polymers (with 50 mol. % of a single A2 
comonomer) or random copolymers (with varying molar ratios of two different A2 
comonomers). The latter approach gives valuable information on the optimal incorporation 
(mol. %) of comonomers to ensure a complete bathochromic shift in fluorescence emission in 
the resultant CPNs while minimising detrimental effects on quantum yield that were found to 
arise from increased interchain aggregation at higher levels of incorporation. The 
compatibility of these nanoparticles with standard cellular imaging and analysis techniques, 
such as microscopy and flow cytometry, has been assessed. 
2. Experimental 
2.1. Materials  
2,7-Dibromo-9,9-dioctyl-9H-fluorene, 1, was synthesised from 2,7-dibromofluorene (97%, 
Sigma Aldrich) using standard literature procedures.[25, 26] 2,2'-(9,9-Dioctyl-9H-fluorene-
2,7-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane), 2, was prepared from 1, again using a 
standard literature procedure.[27] 4,7-Dibromo-2,1,3-benzothiadiazole, 3,  was prepared in 
two steps from o-phenylenediamine (>99%, Sigma Aldrich) by modification of a literature 
method.[28] The method employed was identical save that in the first step direct extraction 
into dichloromethane of the intermediate, 2, 1, 3-benzothiadiazole, from acid solution was 
employed rather than steam distillation, and the isolated compound was then directly 
brominated to give 3. The spectroscopic data for each compound was in agreement with that 
reported in the literature. Amberlite XAD-2 resin, tetrakis(triphenylphosphine)palladium(0) 
and monomer 4 were purchased from Sigma Aldrich. All commercially sourced compounds 
were used as received, without further purification.  
2.2. Miniemulsion Polymerisation 
The following procedure for the synthesis of NP1a is representative of the method used to 
synthesise all of the CPN samples discussed. Sodium dodecyl sulfate (50.0 mg) and 
deionized water (20 mL) were transferred to a Schlenk tube and the resultant solution was 
degassed by bubbling with argon for 20 minutes. Monomers 1  (50.0 mg, 9.12 x 10-2 mmol) 
and 2 (58.6 mg, 9.12 x 10-2 mmol) were dissolved in toluene (1.00 mL), to which hexade-
cane (78 µL) was also added, and this solution was degassed for 5 minutes in the same 
manner. Tetrakis(triphenylphosphine)palladium(0) (2.2 mg,  1.90 x  10-3 mmol) was added to 
the monomer solution, which was then transferred to the reaction vessel. The reaction 
mixture was emulsified by ultrasonication (Cole Parmer 750W ultrasonicator, fitted with 
microtip, set to 22 % power) for 2 minutes while cooling with an ice bath. The Schlenk tube 
was resealed and the miniemulsion was heated to 72 °C, followed by addition of 1M aqueous 
sodium hydroxide solution (365 µL), and the reaction mixture was stirred for 16 hours. After 
cooling to room temperature, the cap of the reaction vessel was removed and the emulsion 
was stirred for 5 hours to remove the residual toluene. The effective conjugated polymer 
concentration generated in this particular miniemulsion is approx. 3500 ppm, higher than that 
typical achievable via nanoprecipitation.   
Note: For NP1b, the amount of water used in the reaction was halved (10 mL) compared to 
the amount used for synthesis of NP1a. This equates to an effective conjugated polymer 
concentration in the resultant miniemulsion of approx. 7000 ppm. For NP2a-c and NP3a-b 
the only change to the procedure described for NP1a is the choice of comonomers and the 
molar ratio of these monomers (Table 1). In each reaction, the total number of moles of the 
combined comonomers was 1.82 x 10-1 mmol. 
2.3. Surfactant Removal  
To prepare the nanoparticle dispersions for use in cellular assays, a 4 mL aliquot of the as-
prepared dispersion was added to 200 mg of Amberlite XAD-2 resin (prewashed twice with 
deionised water) and this suspension was shaken at room temperature for one hour. The resin 
was removed by decantation of the aqueous nanoparticle dispersion (using a syringe with a 
fine needle) and a fresh batch of resin (200 mg) was subsequently added. After shaking for a 
further hour, the nanoparticle dispersion was similarly decanted and then filtered through 
glass wool to remove any residual beads of the Amberlite XAD-2. 
2.4. Characterisation 
2.4.1. DLS Analysis 
DLS particle size analysis of the nanoparticles in water was carried out after dilution of the 
as-prepared aqueous nanoparticle dispersion (400 µL) with deionised water (1.6 mL) and 
surfactant removal (as described above, using 2 x 20 mg of Amberlite XAD-2), using a 
Malvern Zetasizer Nano ZS. All DLS particle size analyses were carried out at a controlled 
temperature of 20 °C. 
2.4.2. GPC Analysis 
In order to prepare THF solutions of the linear CPs that comprise NP1a-b, NP2a-c and 
NP3a-b, a 200 μL aliquot of the as-prepared nanoparticle dispersion was flocculated through 
addition of 1.3 mL methanol and the polymer was isolated by centrifugation (14,000 rpm, 1 
minute) and decantation of the supernatant. The polymer was dried in air to remove residual 
methanol before dissolving in tetrahydrofuran (1 mL) and the resultant solution was filtered 
through a 0.45 μm syringe filter. GPC analysis was carried out at 35 °C using a Viscotek 
GPCmax VE2001 solvent/sample module with 2 × PL gel 10 μm Mixed-B and PL gel 500A 
columns, a Viscotek VE3580 RI detector and a VE 3240 UV/VIS 50 multichannel detector. 
The flow rate was 1 mL/min and the system was calibrated with low polydispersity 
polystyrene standards in the range of 200 to 180 ×104 g mol-1 from Agilent. The analysed 
samples contained n-dodecane as a flow marker. 
2.4.3. UV/Vis and PL Analysis 
 For recording of absorption and emission spectra in water, the aqueous nanoparticle 
dispersion (as-prepared for DLS analysis, described above) was diluted with water to an 
optical density of between 0.5 and 1. UV-Vis absorption spectra of the nanoparticles at this 
concentration were recorded on a Varian Cary 55 5000UV-Vis- NIR spectrophotometer at 
room temperature. PL spectra were recorded on a Varian Cary Eclipse fluorimeter. 
<Table 1 inserted here> 
2.4.4. PLQY Analysis  
All PLQY measurements were obtained using a Fluoromax-4 spectrofluorometer with 
integrating sphere attachment (instrument standardized with a Tungsten lamp). Nanoparticle 
suspensions in water were diluted to an optical density < 0.2 for measurements. Background 
reference measurements were obtained using water (600 µL) in 7 x 40 mm clear glass vials. 
Nanoparticle suspensions (600 µL) were also measured in 7 x 40 mm clear glass vials. An 
excitation wavelength of 390 nm was used for all samples apart from F8BT nanoparticles 
NP2c, for which the excitation wavelength was 440 nm. To calculate PLQYs, four 
measurements were obtained: i) background scatter (e. g. 380-400 or 430-450 nm); ii) 
background fluorescence (400-760 nm); iii) sample scatter (e. g 380-400 nm or 430-450 nm); 
and iv) sample fluorescence (400-760 nm). Appropriate optical filters were used to avoid 
oversaturation of the detector during collection of scatter measurements and these filters were 
corrected for in the PLQY calculation. For each sample of nanoparticles, PLQY 
measurements were repeated in triplicate, using a fresh suspension after each set of sample 
scatter and sample fluorescence measurements. The reported PLQY value is therefore an 
average of three measurements. 
 2.4.5. TEM Analysis 
 Solutions of graphene oxide were synthesised as reported previously.[29] Aqueous solutions 
of graphene oxide (0.10 mg/mL) were sonicated for 30 s prior to use. Lacey carbon grids 
(400 Mesh, Cu) (Agar Scientific) were cleaned using air plasma from a glow-discharge 
system (2 min, 20 mA). The TEM grids were placed on a filter paper and one drop (≈ 0.08 
mL) of the sonicated GO solution was deposited onto each grid from a height of ≈ 1 cm, 
allowing the filter paper to absorb the excess solution, and the grids were left to air-dry in a 
desiccator cabinet for ≈ 60 min. 5 µL of the nanoparticle dispersion (100 ppm) was pipetted 
onto a GO grid and blotted away with filter paper after 2 minutes, the grid was then left to 
air-dry in a desiccator cabinet for ≈ 60 min. Brightfield TEM images were captured with a 
transmission electron microscope (JEOL 2000FX), operating at 200 kV. Average sizes of the 
nanoparticles were determined from counting the sizes of 200 particles for each sample. 
2.4.6. Cell Culture 
HCT116, A549 and MCF-7 cells were obtained from ATCC. All cell lines were maintained 
in RPMI-1640 media supplemented with 10 % heat inactivated fetal calf serum and 0.2 mM 
L-glutamine in a humidified incubator with 5 % CO2. 
2.4.7. Viability Assay  
Cells were seeded in 96 well plates at 10,000 cells per well 24 hours prior to use. Cells were 
incubated with particles diluted in Optimem media (Life Technologies) at the stated 
concentrations for 24 hours. The media was aspirated and the cells washed once in PBS. The 
cells were then incubated with Alamar Blue reagent (Life technologies) for 1 hour and 
fluorescence was measured at excitation 585 nm emission 610 nm.  
2.4.8. Confocal Microscopy 
HCT-116 cells were seeded on cover glass slides. After 24 hours they were incubated with 
particles (50 µg/ml in Optimem) for 2 hours after which time they were washed three times in 
cold PBS.  NP2c samples were counterstained with CellMask™ Deep Red Plasma membrane 
stain (Life Technologies) and Hoechst 33342 for 5 minutes at 37 °C. Cells were fixed for 5 
minutes at room temperature in 4 % paraformaldehyde-PBS prior to imaging using a 
LSM710 META confocal microscope (Zeiss). 
2.4.9. Flow Cytometry 
Cells were seeded on 6 well tissue culture plates for 24 hours. They were incubated with 50 
µg/ml particles for 2 hours then washed three times in ice cold PBS. Cells were trypsinized 
and fixed in 4 % paraformaldehyde –PBS for 5 minutes at room temperature. Cells were 
resuspended in PBS and analysed by flow cytometry within 24 hours using a MoFlo XDP 
flow cytometer (Beckman Coulter). Flow cytometer settings were NP1a:  405 nm excitation, 
emission 417.4-482.5 nm; NP2c: 488 nm excitation, emission 515-543 nm; NP3a: 488 nm 
excitation, 655-685 nm emission. 
<Fig. 1. inserted here> 
<Fig. 2. inserted here> 
3. Results and Discussion 
3.1. Miniemulsion Polymerisation and Surfactant Removal 
Initial efforts to develop a versatile route for the direct synthesis of CPNs by Suzuki reaction 
of A2 + B2 monomers focused on the synthesis of CPNs of PFO via copolymerisation of 
equimolar amounts of 2,7-dibromo-9,9-dioctyl-9H-fluorene, 1, and 2,2’-(9,9-dioctyl-9H-
fluorene-2,7-diyl)bis(4,4,5,5-tetramethyl-1,3,2- dioxaborolane), 2. The miniemulsion 
reactions remain stable at dispersed/continuous phase ratios of 1:20 and 1:10. These are 
higher than previously reported (1:25), which has advantages in terms of potential for scale-
up.[23] Previous reports showed that varying the surfactant concentration from 1 – 0.08 wt. 
% decreased the mean particle diameter from 85 to 39 nm.[23] In this contribution, which is 
primarily focused on varying the copolymer structure, a surfactant concentration close to the 
minimum amount necessary to provide a stable miniemulsion throughout the reaction was 
used, e.g. 0.25 and 0.5 wt. % for dispersed/continuous phase ratios of 1:20 and 1:10, 
respectively. The use of a low surfactant concentration minimised the number of purification 
cycles necessary for removal of free surfactant in the final dispersions. TEM analysis of 
NP1a and NP1b (produced with dispersed/continuous phase ratios of 1:20 and 1:10 
respectively), showed that nanoparticles obtained by this method generally have a spherical 
morphology (see Figure 1). There is some disparity in size between the distributions obtained 
via DLS and TEM for all samples (see Table 1), due to the relatively polydisperse nature of 
the samples. However, both methods are in agreement that the majority of particles present in 
all samples are below 100 nm in diameter and thus readily amendable to entry into cells by 
active mechanisms, e.g. endocytosis.[30] Moreover, CPNs prepared by precipitation with a 
similar level of polydispersity within this size regimen have been successfully employed in 
real-time sentinel lymph node mapping in vivo.[7] 
Purification of the CPNs for application in cellular imaging requires removal of the organic 
solvent (toluene) and free surfactant. Removing the lid of the reaction vessel and stirring at 
room temperature for 5 hours achieved the former, while the latter can be achieved by an 
exhaustive dialysis of the dispersion (7 days, changing the water twice daily). However, 
dialysis is both time-consuming, causing a considerable bottleneck in CPN production, and 
expensive, hence an alternative strategy was investigated. In protein purification detergent 
removal (ionic and non-ionic surfactants) can be achieved by the use of a porous, 
hydrophobic polystyrene resin, Amberlite XAD-2.[31, 32] It was found that for the CPNs 
prepared in this work it was possible to remove both the residual toluene and the SDS to a 
final level that is below the surfactant CMC by simply shaking the crude nanoparticle 
suspension (as a 5-fold dilution) with 1 wt. % of Amberlite XAD-2 for 15 minutes and then 
repeating this process with a fresh batch of resin.  Analysis of the samples purified by this 
method by DLS shows no detrimental effects on the CPN size or polydispersity (Table 1). 
Unlike dialysis, purification using the resin does not remove the aqueous base (sodium 
hydroxide) employed in the polymerisation, however it was at a sufficiently low level that the 
as-purified CPN suspension could be added directly to biological buffer solutions without the 
need for further purification. Using this approach it is possible to produce sub-100 nm PFO 
nanoparticles at high concentrations (NP1b, Table 1), however these more concentrated 
samples (1:10, dispersed/continuous) tended to flocculate after surfactant removal by 
treatment with Amberlite XAD-2 resin upon standing for several hours. Hence in all 
subsequent copolymerisation reactions a dispersed/continuous phase ratio of 1:20 was 
employed as these dispersions can be stored for several months following surfactant removal, 
without dilution. 
Measurement of UV/vis and PL spectra of NP1a in dilute aqueous suspension, indicated that 
the PFO adopts a mixture of glassy phase (disordered) and β-phase (ordered) chain 
morphologies within the nanoparticles (Figure 2). The β-phase is an ordered form of PFO in 
which the backbones of neighbouring polymer chains are planarized with respect to each 
other.[33] This is consistent with the findings of a number of previous reports in which 
aqueous dispersions of PFO nanoparticles have been processed from (or annealed with) a 
“good” solvent.[34, 35] The photoluminescence quantum yield (PLQY) of NP1a in water (38 
%) is similar to values reported for PFO NPs prepared by other methods.[23, 34] In order to 
assess the degree of polymerisation obtained by Suzuki polymerisation in a miniemulsion, 
small aliquots of the as-made CPN suspensions were flocculated through addition of 
methanol and the molecular weight of the isolated polymers (in THF) was determined by gel 
permeation chromatography (Table 1).  The molecular weights of PFO recovered from NP1a 
and NP1b emulsions (Mn = 1.4 – 1.5 x 104 g mol-1) compared favourably with those 
produced by reaction of an A-B monomer in the earlier report (9.0 x 103 – 2.3 x 104 g mol-
1),[23] indicating that A2 + B2 reactions can provide an acceptably high degree of 
polymerisation while providing the possibility of vastly expanding the structural diversity. 
3.2. Green-Emitting CPNs 
The emission wavelength of fluorene polymers can be tuned through copolymerisation of 
fluorene with various electron withdrawing co-monomers.[36, 37] Miniemulsion co-
polymerisation of dioctyl fluorene monomers 1 and 2 with benzothiadiazole monomer 3 gave 
CPN dispersions, NP2a-c, that luminesce primarily in the green (Table 2). NP2a and NP2b 
are comprised of random copolymers, synthesised by reaction of 1 and 2 with 5 and 10 mol. 
% of 3, respectively. The UV/vis absorption spectra of NP2 are similar to those of NP1 
(Figure 3) due to the relative abundance of fluorene-fluorene segments in these materials.  
The secondary absorption peak observed at 437 nm for NP2 shows that the polymers in these 
nanoparticles retain the ability to form the more ordered β-phase conformation, despite the 
incorporation of small amounts of the benzothiadiazole units.[38] The absorbance of the 
fluorene-benzothiadiazole segments in NP2 is observed as a broad shoulder that partially 
overlaps with the β-phase absorption and that extends to around 500 nm (Figure 3a). The PL 
emission of these copolymers (exciting at 390 nm) is almost exclusively derived from the 
relatively few fluorene-benzothiadiazole chain segments, as a result of efficient Förster 
Resonance Energy Transfer (FRET) between these and the fluorene-fluorene segments 
(Figure 3b).  As a result, the effective Stokes shift for both samples is large (154 nm). 
Increasing the amount of benzothiadiazole monomer 3 from 5 to 10 mol. % resulted in a  
significant  increase  in the  PLQY (Table 2) of the resultant nanoparticles, NP2a and NP2b, 
with the value for the latter (56 %) being much higher than those typically reported for green 
emitting CPNs.  
<Fig. 3. inserted here> 
<Fig. 4. inserted here> 
This is analogous to the recent findings of McNeill et al., who report that CPNs comprised of 
blends of PFBT and MEH-PPV have a higher PLQY than CPNs comprised of PFBT 
alone.[39] Considering the relative complexity of the three monomer reaction, the observed 
polymer molecular weights (1.3-1.4 x 104 g mol-1, Table 1) are encouraging, highlighting the 
robustness and efficiency of the miniemulsion polymerisation reactions. Polymerisation of a 
1:1 molar ratio of 2 and 3 gave CPN dispersion NP2c, consisting of the well-studied 
alternating co-polymer F8BT.[36] The broad and featureless UV/vis and PL spectra (Figure 
4) and moderate quantum efficiency (12 %) for NP2c are consistent with previous  examples 
of  F8BT  CPNs that have been prepared by nanoprecipitation.[14] Incorporation of relatively 
small amounts (5-10 %) of benzothiadiazole into a random co-polymer based on PFO gives 
green-emitting CPNs with significantly higher quantum efficiencies than CPNs of the exactly 
alternating co-polymer (F8BT). 
<Table 2 inserted here> 
<Fig. 5. Inserted here> 
3.3. FR-NIR Emitting CPNs 
In order to facilitate their use for in vivo imaging applications, there is currently considerable 
focus on the development of CPNs that emit in the FR/NIR region.[5-9] However, this 
remains a considerable challenge due to the limited solubility of low bandgap conjugated 
polymers and their tendency to aggregate in the solid state. The former characteristic renders 
these polymers less suitable for post-polymerisation fabrication into CPNs via 
nanoprecipitation and the latter significantly impacts upon the PLQY of the resultant 
nanomaterials.[9]   Incorporation of the thiophene-benzothiadiazole-thiophene monomer 4 (1 
– 35 mol. %) into PFO-based random copolymers in a conventional solution-based Suzuki 
coupling polymerisation has been shown to produce materials that display FR/NIR solid state 
emission when deposited as thin films.[37] Suzuki miniemulsion polymerisation reactions 
were carried out using 1 and 2 as comonomers, with 5 and 10 mol. % of 4 to give 
nanoparticle dispersions NP3a and NP3b, respectively. It was not possible to incorporate 
higher loadings of 4 into these dispersions due to the limited solubility of 4 in toluene at room 
temperature (the temperature at which the emulsification step is performed). In the case of 
NP3b, it was observed that a small amount of monomer 4 had precipitated during 
emulsification, and hence the maximum possible mol. % for incorporation of this comonomer 
into CPNs by this method lies between 5 and 10 mol. %. The precipitation of monomer 4 
resulted in a reduction in the molecular weight of the polymer (5.7 x 103 g mol-1) contained 
within these nanoparticles, when compared with those produced in the other miniemulsion 
reactions (see Table 1). GPC analysis of the polymer from NP3a indicated a number average 
molecular weight of 1.2 x 104 g mol-1, corresponding to a degree of polymerisation of around 
30 and therefore an average of 3 segments derived from monomer 4 per chain. UV/vis 
absorption spectra of NP3a and NP3b indicated that the more abundant fluorene-fluorene 
segments of the polymer chains can adopt glassy phase and β-phase conformations (Figure 
5a). The β-phase absorption is significantly lower for composition NP3b than NP3a. The 
absorption spectra also have a broad absorption peak with a maximum at 529 nm, associated 
with the less abundant, lower bandgap segments derived from monomer 4. The emission 
spectra of NP3a and NP3b exhibited primarily red fluorescence (λem = 630 nm, exciting at 
390 nm), with a significant amount of this fluorescence encompassing the FR/NIR region 
(Figure 5b). Unlike the green-emitting CPNs discussed above, in which complete energy 
transfer from the blue to green segments is observed in all cases, NP3a and NP3b both 
exhibit a small amount of fluorescence in the blue region, corresponding to emission from 
segments of β-phase PFO. Previous attempts to form efficient FR/NIR CPNs have focused on 
the nanoprecipitation of poly[(9,9-dihexylfluorenyl-co-2,1,3-benzothiadiazole)-co-4,7-
di(thiophen-2-yl)-2,1,3-benzothiadiazole (PFBTDBT), in which the lower energy fluorene-
benzothiadiazole (green-emitting) segments have a better overlap with the higher energy, red-
segments than the fluorene-fluorene segments (blue-emitting) segments found in NP3.[5] 
Despite evidence of some blue emission, NP3a has a high PLQY (34 %) by comparison with 
alternative FR/NIR nanoparticles and are thus promising candidates for in vivo bioimaging 
applications. NP3b, with 10 mol. % of monomer 4, has a slightly lower PLQY (19 %). 
Factors that may contribute to the lower efficiency of NP3b when compared to NP3a are the 
lower molecular weight of the CP chains in NP3b and the increased interchain aggregation 
caused by the higher mol. % of red-emitting segments.  This is evidenced by the reduced 
amount of PFO β-phase observed in the UV/vis spectrum of NP3b (Figure 5b).  
<Fig. 6. inserted here> 
<Fig. 7. inserted here> 
<Fig. 8. inserted here> 
3.4. Cellular Imaging and Cytotoxicity Assays 
The suitability of nanoparticle dipersions NP1a, NP2c and NP3a (blue, green and red 
emitting, respectively) for bioimaging was tested in 2D cell cultures. Each type of 
nanoparticle was shown to be detectable by flow cytometry at 50 µg/mL after a 2 hour 
incubation, demonstrating the potential to utilize these materials for FACS analysis 
experiments (Figure 6). Confocal microscopy revealed rapid internalisation of the CPNs into 
HCT116 cells in all cases, with a largely perinuclear localisation (Figure 7). However NP3a 
showed significant bleed though into blue, green and red channels making them impractical 
for multiplexing with many standard imaging reagents such as Hoechst 33342 and DAPI. In 
contrast, NP2c was compatible with reagents including Hoechst 33342, DAPI, CellMask™ 
Deep Red Plasma membrane (Figure 7) and red fluorescent protein (RFP) (data not shown) 
demonstrating that it is a good candidate for use in microscopy studies. The cytotoxicity of 
nanoparticles NP1a, NP2c and NP3a was tested using the Alamar Blue assay. After 
incubation for 24 hours the particles reduced viability by a maximum of 25 % of untreated 
controls (Table 3). At higher concentrations the viability dropped further (Figure 8) however 
such high concentrations were well beyond those necessary for bioimaging purposes. 
<Table 3. inserted here> 
4. Conclusions 
We have demonstrated the wider utility of Suzuki emulsion polymerisation for the direct 
synthesis of CPNs with tunable fluorescence emission. Their useful optical properties, such 
as high PLQYs, and small size (< 100 nm) render these nanoparticles suitable for use in 
biological applications, such as cellular imaging and sorting via fluorescence microscopy and 
flow cytometry. The methodology developed is straightforward in terms of both synthesis 
and purification and more readily scalable than many previously reported methods for 
producing CPNs. Through developing a deeper understanding of the mechanism of Suzuki 
emulsion polymerisation reactions and, in particular, the factors that control particle size, and 
use of biocompatible surfactants, one pot synthesis of CPNs has the potential to supersede 
current indirect methodologies (e. g. nanoprecipitation) and to support the wider use of these 
materials in biomedical imaging. 
References 
[1] L.P. Fernando, P.K. Kandel, J. Yu, J. McNeill, P.C. Ackroyd, K.A. Christensen, Biomacromolecules, 
11 (2010) 2675-2682. 
[2] J. Lee, M. Twomey, C. Machado, G. Gomez, M. Doshi, A.J. Gesquiere, J.H. Moon, Macromolecular 
Bioscience, 13 (2013) 913-920. 
[3] M. Green, P. Howes, C. Berry, O. Argyros, M. Thanou, Proceedings of the Royal Society A: 
Mathematical, Physical and Engineering Sciences, 465 (2009) 2751-2759. 
[4] R. Ahmad Khanbeigi, T.F. Abelha, A. Woods, O. Rastoin, R.D. Harvey, M.-C. Jones, B. Forbes, M.A. 
Green, H. Collins, L.A. Dailey, Biomacromolecules, 16 (2015) 733-742. 
[5] D. Ding, J. Liu, G. Feng, K. Li, Y. Hu, B. Liu, Small, 9 (2013) 3093-3102. 
[6] K. Li, D. Ding, D. Huo, K.-Y. Pu, N.N.P. Thao, Y. Hu, Z. Li, B. Liu, Advanced Functional Materials, 22 
(2012) 3107-3115, S3107/3101-S3107/3107. 
[7] S. Kim, C.-K. Lim, J. Na, Y.-D. Lee, K. Kim, K. Choi, J.F. Leary, I.C. Kwon, Chemical Communications 
(Cambridge, United Kingdom), 46 (2010) 1617-1619. 
[8] C. Wu, S.J. Hansen, Q. Hou, J. Yu, M. Zeigler, Y. Jin, D.R. Burnham, J.D. McNeill, J.M. Olson, D.T. 
Chiu, Angewandte Chemie, International Edition, 50 (2011) 3430-3434, S3430/3431-S3430/3414. 
[9] J. Liu, G. Feng, D. Ding, B. Liu, Polymer Chemistry, 4 (2013) 4326-4334. 
[10] A.L. Koner, D. Krndija, Q. Hou, D.J. Sherratt, M. Howarth, ACS Nano, 7 (2013) 1137-1144. 
[11] M.C. Mancini, B.A. Kairdolf, A.M. Smith, S. Nie, Journal of the American Chemical Society, 130 
(2008) 10836-10837. 
[12] C. Szymanski, C. Wu, J. Hooper, M.A. Salazar, A. Perdomo, A. Dukes, J. McNeill, Journal of 
Physical Chemistry B, 109 (2005) 8543-8546. 
[13] C. Wu, C. Szymanski, J. McNeill, Langmuir, 22 (2006) 2956-2960. 
[14] C. Wu, B. Bull, C. Szymanski, K. Christensen, J. McNeill, ACS Nano, 2 (2008) 2415-2423. 
[15] K. Landfester, R. Montenegro, U. Scherf, R. Guntner, U. Asawapirom, S. Patil, D. Neher, T. 
Kietzke, Advanced Materials (Weinheim, Germany), 14 (2002) 651-655. 
[16] K. Li, R. Zhan, S.-S. Feng, B. Liu, Analytical Chemistry (Washington, DC, United States), 83 (2011) 
2125-2132. 
[17] T. Kietzke, D. Neher, K. Landfester, R. Montenegro, R. Guentner, U. Scherf, Nature Materials, 2 
(2003) 408-412. 
[18] E. Hittinger, A. Kokil, C. Weder, Angewandte Chemie, International Edition, 43 (2004) 1808-
1811. 
[19] J. Pecher, J. Huber, M. Winterhalder, A. Zumbusch, S. Mecking, Biomacromolecules, 11 (2010) 
2776-2780. 
[20] M.C. Baier, J. Huber, S. Mecking, Journal of the American Chemical Society, 131 (2009) 14267-
14273. 
[21] R. Wang, C. Zhang, W. Wang, T. Liu, Journal of Polymer Science, Part A: Polymer Chemistry, 48 
(2010) 4867-4874. 
[22] H. Li, X. Wu, B. Xu, H. Tong, L. Wang, RSC Advances, 3 (2013) 8645-8648. 
[23] C. Negele, J. Haase, A. Leitenstorfer, S. Mecking, ACS Macro Letters, 1 (2012) 1343-1346. 
[24] D. Muenmart, A.B. Foster, A. Harvey, M.-T. Chen, O. Navarro, V. Promarak, M.C. McCairn, J.M. 
Behrendt, M.L. Turner, Macromolecules (Washington, DC, United States), 47 (2014) 6531-6539. 
[25] R. Grisorio, P. Mastrorilli, C.F. Nobile, G. Romanazzi, G.P. Suranna, D. Acierno, E. Amendola, 
Macromolecular Chemistry and Physics, 206 (2005) 448-455. 
[26] M.R. Craig, M.M. de Kok, J.W. Hofstraat, A.P.H.J. Schenning, E.W. Meijer, Journal of Materials 
Chemistry, 13 (2003) 2861-2862. 
[27] S.Y. Cho, A.C. Grimsdale, D.J. Jones, S.E. Watkins, A.B. Holmes, Journal of the American Chemical 
Society, 129 (2007) 11910-11911. 
[28] Y. Jin, Y. Kim, S.H. Kim, S. Song, H.Y. Woo, K. Lee, H. Suh, Macromolecules (Washington, DC, 
United States), 41 (2008) 5548-5554. 
[29] N.R. Wilson, P.A. Pandey, R. Beanland, R.J. Young, I.A. Kinloch, L. Gong, Z. Liu, K. Suenaga, J.P. 
Rourke, S.J. York, J. Sloan, ACS Nano, 3 (2009) 2547-2556. 
[30] J. Rejman, V. Oberle, I.S. Zuhorn, D. Hoekstra, Biochemical Journal, 377 (2004) 159-169. 
[31] P.S.J. Cheetham, Analytical Biochemistry, 92 (1979) 447-452. 
[32] M. Hiraide, T. Shima, H. Kawaguchi, Analytical Sciences, 10 (1994) 505-507. 
[33] A. Monkman, C. Rothe, S. King, F. Dias, Advances in Polymer Science, 212 (2008) 187-225. 
[34] C. Wu, J. McNeill, Langmuir, 24 (2008) 5855-5861. 
[35] J.M. Behrendt, A.B. Foster, M.C. McCairn, H. Willcock, R.K. O'Reilly, M.L. Turner, Journal of 
Materials Chemistry C: Materials for Optical and Electronic Devices, 1 (2013) 3297-3304. 
[36] Y. He, S. Gong, R. Hattori, J. Kanicki, Applied Physics Letters, 74 (1999) 2265-2267. 
[37] Q. Hou, Y. Xu, W. Yang, M. Yuan, J. Peng, Y. Cao, Journal of Materials Chemistry, 12 (2002) 2887-
2892. 
[38] D.W. Bright, F.B. Dias, F. Galbrecht, U. Scherf, A.P. Monkman, Advanced Functional Materials, 19 
(2009) 67-73. 
[39] X. Wang, L.C. Groff, J.D. McNeill, Journal of Physical Chemistry C, 118 (2014) 25731-25739. 
 
 
Figure Captions 
Scheme 1. Selection of monomers employed in miniemulsion polymerisation reactions and 
resultant copolymers from which CPNs are comprised. 
Table 1. Composition, particle size and copolymer molecular weight of CPNs synthesized via 
Suzuki polymerisation in a miniemulsion. 
Fig. 1. TEM of PFO nanoparticles prepared with dispersed/continuous phase ratios of 1:20, 
NP1a, and 1:10, NP1b (scale bar = 100 nm). 
Fig. 2. UV/vis and PL spectra (λex = 390 nm) of NP1a in water. 
Fig. 3. a) UV/vis and b) PL emission spectra (λex = 390 nm) of NP2a and NP2b in water. 
Fig. 4. UV/vis and PL emission spectra (λex = 465 nm) of NP2c in water. 
Table 2. Optical properties of CPNs in water. 
Fig. 5. a) UV/vis and b) PL emission spectra (λex = 390 nm) of NP3a and NP3b in water. 
Fig. 6. Flow cytometric analysis: HCT116 cells incubated with 50 ug/ml of nanoparticles 
NP1a, NP2c or NP3a for 2 hours. Cell only: filled histogram; nanoparticle incubated cells: 
unfilled histogram. Calculated % of nanoparticle-labelled cells shown in each case. 
Fig. 7. Confocal microscopy of particles in HCT116 cells. After a 2 hour incubation cells 
were either fixed (NP1a, NP3a) or stained with Hoechst 33342 and CellMask™ Deep Red 
Plasma membrane prior to fixing (NP2c) and visualisation by confocal microscopy (Scale bar 
= 10 µm). NP1a: particles-blue; NP2c: nucleus-blue, particles-green, plasma membrane-red; 
NP3a: particles-red. 
Fig. 8. Cytotoxicity of particles in three cell lines. Cells HCT116, MCF7, A549 were 
incubated with particles at the stated concentrations for 24 hours after which time the cell 
viability was measured using Alamar blue assay. N=4, error bar SD. 
Table 3. Mean cell viability after 24 hour incubation with 50 µg/ml of particles. 
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Tables 
Table 1 
Sample code Co-monomers Co-monomer 
ratio (mol. %) 
DDLSa 
(nm) 
PdIb DTEMc 
(nm) 
Mnd 
(g mol-1) 
Mw/Mnd 
NP1a 1 + 2 50 : 50 71 0.16 23 ± 12 1.4 x 104 2.4 
NP1be 1 + 2 50 : 50 43 (35%), 
13 (65%)f 
0.20 19 ± 9  1.5 x 104 2.4 
NP2a 1 + 2 + 3 45 : 50 : 5 45 0.17 24 ± 15 1.3 x 104 2.9 
NP2b 1 + 2 + 3 40 : 50 : 10 28 0.16 21 ± 8 1.4 x 104 2.8 
NP2c 2 + 3 50 : 50 73 0.16 23 ± 15 9.4 x 103 2.3 
NP3a 1 + 2 + 4 45 : 50 : 5 55 0.19 25 ± 11 1.2 x 104 1.9 
NP3b 1 + 2 + 4 40 : 50 : 10 59 (75%), 
25 (25%)f 
0.17 21 ± 11 5.7 x 103 3.4 
a Mean diameter by number; b polydispersity index for the Gaussian size distribution measured via DLS; c mean diameter 
determined measuring 200 particles from TEM images; d molecular weight of polymer chains that comprise the nanoparticles 
following flocculation, centrifugation and dissolution in THF; e this sample was prepared with a dispersed/continuous phase ratio 
of 1:10, while this ratio was 1:20 for all other samples; f biomodal size distribution indicated for this sample. 
 
 
Table 2 
Sample code λmax (nm) λem (nm) φ (%) 
NP1a 405 440 38 ± 2 
NP1b 405 440 23 ± 2 
NP2a 380 534 41 ± 3 
NP2b 379 534 56 ± 1 
NP2c 334, 466 537 12 ± 1 
NP3a 382 631 34 ± 3 
NP3b 380 633 19 ± 1 
 
 
Table 3 
Cells NP1a NP2c NP3a 
A549 98 % 93 % 100 % 
HCT116 76 % 78 % 117 % 
MCF7 79 % 86 % 108 % 
 
